PrEP Availability Among Health Facilities Participating in the Global IeDEA Consortium-Reference-Cited by-同舟云学术

PrEP Availability Among Health Facilities Participating in the Global IeDEA Consortium

Published:2023-12-22 Issue: Volume: Page:
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Kebede Samuel¹,Brazier Ellen²³,Freeman Aimee M.⁴,Muwonge Timothy R.⁵,Choi Jun Yong⁶,de Waal Renee⁷,Poda Armel⁸,Cesar Carina⁹,Munyaneza Athanase¹⁰,Kasozi Charles¹¹,Pasayan Mark Kristoffer U.¹²,Althoff Keri N.¹³,Shongo Alisho¹⁴,Low Nicola¹⁵,Ekouevi Didier¹⁶,Veloso Valdiléa G.¹⁷,Ross Jonathan¹⁸

Affiliation:

1. Department of Medicine, New York University Grossman School of Medicine

2. Institute for Implementation Science in Population Health, City University of New York

3. Graduate School of Public Health and Health Policy, City University of New York, New York, NY

4. Johns Hopkins University, Baltimore, MD, USA

5. Infectious Diseases Institute, Makerere University, Kampala Uganda

6. Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

7. Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa

8. Hôpital de Jour, Service des Maladies Infectieuses, CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso

9. Fundación Huésped, Buenos Aires, Argentina

10. Rwanda Military Hospital, Kigali, Rwanda

11. Masaka Regional Referral Hospital, Uganda

12. Research Institute for Tropical Medicine, Muntinlupa City, Philippines

13. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

14. School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo

15. Institute of Social and Preventive Medicine, Bern, Switzerland

16. Université de Lomé, Lomé, Togo

17. Instituto Nacional de Infectologia Evandro Chagas, Rio de Janerio, Brazil

18. Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.

Abstract

Background: While recognized as a key HIV prevention strategy, preexposure prophylaxis (PrEP) availability and accessibility are not well documented globally. We aimed to describe PrEP drug registration status and the availability of PrEP services across HIV care sites participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium. Methods: We used country-level PrEP drug registration status from the AIDS Vaccine Advocacy Coalition and data from IeDEA surveys conducted in 2014, 2017 and 2020 among participating HIV clinics in seven global regions. We used descriptive statistics to assess PrEP availability across IeDEA sites serving adult patients in 2020 and examined trends in PrEP availability among sites that responded to all three surveys. Results: Of 199 sites that completed the 2020 survey, PrEP was available in 161 (81%). PrEP availability was highest at sites in North America (29/30; 97%) and East Africa (70/74; 95%) and lowest at sites in Central (10/20; 50%) and West Africa (1/6; 17%). PrEP availability was higher among sites in countries where PrEP was officially registered (146/161; 91%) than where it was not (14/32; 44%). Availability was higher at health centers (109/120; 90%) and district hospitals (14/16; 88%) compared to regional/teaching hospitals (36/63). Among the 94 sites that responded to all three surveys, PrEP availability increased from 47% in 2014 to 60% in 2017 and 76% in 2020. Conclusion: PrEP availability has substantially increased since 2014 and is now available at most IeDEA sites. However, PrEP service provision varies markedly across global regions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy